Titre : Tumeurs de la moelle osseuse

Tumeurs de la moelle osseuse : Questions médicales fréquentes

Termes MeSH sélectionnés :

Streptococcus
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Tumeurs de la moelle osseuse : Questions médicales les plus fréquentes", "headline": "Tumeurs de la moelle osseuse : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Tumeurs de la moelle osseuse : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-04-14", "dateModified": "2025-04-09", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Tumeurs de la moelle osseuse" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Tumeurs hématologiques", "url": "https://questionsmedicales.fr/mesh/D019337", "about": { "@type": "MedicalCondition", "name": "Tumeurs hématologiques", "code": { "@type": "MedicalCode", "code": "D019337", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C15.378.400" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Polyglobulie primitive essentielle", "alternateName": "Polycythemia Vera", "url": "https://questionsmedicales.fr/mesh/D011087", "about": { "@type": "MedicalCondition", "name": "Polyglobulie primitive essentielle", "code": { "@type": "MedicalCode", "code": "D011087", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C15.378.400.200.500" } } } ], "about": { "@type": "MedicalCondition", "name": "Tumeurs de la moelle osseuse", "alternateName": "Bone Marrow Neoplasms", "code": { "@type": "MedicalCode", "code": "D019046", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Sa A Wang", "url": "https://questionsmedicales.fr/author/Sa%20A%20Wang", "affiliation": { "@type": "Organization", "name": "Department of Hematopathology, University of Texas MD Anderson Cancer Center, Houston, TX, US." } }, { "@type": "Person", "name": "Adam Bagg", "url": "https://questionsmedicales.fr/author/Adam%20Bagg", "affiliation": { "@type": "Organization", "name": "Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA, US." } }, { "@type": "Person", "name": "Robert P Hasserjian", "url": "https://questionsmedicales.fr/author/Robert%20P%20Hasserjian", "affiliation": { "@type": "Organization", "name": "Department of Pathology, Massachusetts General Hospital, Boston, MA, US." } }, { "@type": "Person", "name": "Eric D Hsi", "url": "https://questionsmedicales.fr/author/Eric%20D%20Hsi", "affiliation": { "@type": "Organization", "name": "Department of Pathology, Wake Forest School of Medicine, Winston-Salem, NC, US." } }, { "@type": "Person", "name": "Kathryn Foucar", "url": "https://questionsmedicales.fr/author/Kathryn%20Foucar", "affiliation": { "@type": "Organization", "name": "Department of Pathology, University of New Mexico, Albuquerque, NM, US." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Gene Rearrangement and Modification of Immunity Factors Are Correlated with the Insertion of Bacteriocin Cassettes in Streptococcus mutans.", "datePublished": "2022-05-23", "url": "https://questionsmedicales.fr/article/35604175", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1128/spectrum.01806-21" } }, { "@type": "ScholarlyArticle", "name": "Prosthetic knee joint infection caused by α-hemolytic Streptococcus species: a case report.", "datePublished": "2023-07-26", "url": "https://questionsmedicales.fr/article/37496037", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s13256-023-03905-1" } }, { "@type": "ScholarlyArticle", "name": "Comparative genome analysis of Streptococcus strains to identify virulent genes causing neonatal meningitis.", "datePublished": "2022-12-24", "url": "https://questionsmedicales.fr/article/36572056", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.meegid.2022.105398" } }, { "@type": "ScholarlyArticle", "name": "A respiratory Streptococcus strain inhibits Acinetobacter baumannii from causing inflammatory damage through ferroptosis.", "datePublished": "2024-10-28", "url": "https://questionsmedicales.fr/article/39465358", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12866-024-03589-7" } }, { "@type": "ScholarlyArticle", "name": "Long-term Risk of Epilepsy Following Invasive Group B Streptococcus Disease in Neonates in Denmark.", "datePublished": "2023-04-03", "url": "https://questionsmedicales.fr/article/37083662", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1001/jamanetworkopen.2023.9507" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Hémopathies et maladies lymphatiques", "item": "https://questionsmedicales.fr/mesh/D006425" }, { "@type": "ListItem", "position": 3, "name": "Hémopathies", "item": "https://questionsmedicales.fr/mesh/D006402" }, { "@type": "ListItem", "position": 4, "name": "Tumeurs hématologiques", "item": "https://questionsmedicales.fr/mesh/D019337" }, { "@type": "ListItem", "position": 5, "name": "Tumeurs de la moelle osseuse", "item": "https://questionsmedicales.fr/mesh/D019046" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Tumeurs de la moelle osseuse - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Tumeurs de la moelle osseuse", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-02", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Tumeurs de la moelle osseuse", "description": "Comment diagnostiquer une tumeur de la moelle osseuse ?\nQuels tests sont utilisés pour confirmer une tumeur ?\nQuels marqueurs tumoraux sont recherchés ?\nQuelle est l'importance de l'analyse cytogénétique ?\nLes tests génétiques sont-ils utiles ?", "url": "https://questionsmedicales.fr/mesh/D019046?mesh_terms=Streptococcus&page=3#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Tumeurs de la moelle osseuse", "description": "Quels sont les symptômes courants des tumeurs de la moelle osseuse ?\nComment la moelle osseuse affecte-t-elle la santé globale ?\nLes symptômes varient-ils selon le type de tumeur ?\nY a-t-il des signes d'alerte précoce ?\nLes symptômes peuvent-ils être confondus avec d'autres maladies ?", "url": "https://questionsmedicales.fr/mesh/D019046?mesh_terms=Streptococcus&page=3#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Tumeurs de la moelle osseuse", "description": "Peut-on prévenir les tumeurs de la moelle osseuse ?\nLes facteurs environnementaux jouent-ils un rôle ?\nLe tabagisme est-il un facteur de risque ?\nLes antécédents familiaux influencent-ils le risque ?\nY a-t-il des vaccins pour prévenir ces tumeurs ?", "url": "https://questionsmedicales.fr/mesh/D019046?mesh_terms=Streptococcus&page=3#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Tumeurs de la moelle osseuse", "description": "Quels traitements sont disponibles pour ces tumeurs ?\nLa radiothérapie est-elle efficace ?\nQu'est-ce que la thérapie ciblée ?\nQuand la greffe de moelle osseuse est-elle recommandée ?\nQuels sont les effets secondaires des traitements ?", "url": "https://questionsmedicales.fr/mesh/D019046?mesh_terms=Streptococcus&page=3#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Tumeurs de la moelle osseuse", "description": "Quelles complications peuvent survenir ?\nComment les infections sont-elles liées aux tumeurs ?\nLes tumeurs de la moelle osseuse peuvent-elles récidiver ?\nQuelles sont les conséquences d'une anémie sévère ?\nLes traitements eux-mêmes peuvent-ils causer des complications ?", "url": "https://questionsmedicales.fr/mesh/D019046?mesh_terms=Streptococcus&page=3#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Tumeurs de la moelle osseuse", "description": "Quels sont les principaux facteurs de risque ?\nLes maladies génétiques augmentent-elles le risque ?\nLe sexe influence-t-il le risque de tumeurs ?\nL'obésité est-elle un facteur de risque ?\nLes infections virales peuvent-elles jouer un rôle ?", "url": "https://questionsmedicales.fr/mesh/D019046?mesh_terms=Streptococcus&page=3#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une tumeur de la moelle osseuse ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic se fait par biopsie de moelle osseuse et analyses sanguines." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour confirmer une tumeur ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests d'imagerie comme l'IRM et la TDM sont souvent utilisés." } }, { "@type": "Question", "name": "Quels marqueurs tumoraux sont recherchés ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Les marqueurs comme le B2-microglobuline et les chaînes légères d'immunoglobulines sont analysés." } }, { "@type": "Question", "name": "Quelle est l'importance de l'analyse cytogénétique ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Elle aide à identifier des anomalies chromosomiques spécifiques aux tumeurs." } }, { "@type": "Question", "name": "Les tests génétiques sont-ils utiles ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Oui, ils peuvent identifier des mutations spécifiques liées aux tumeurs." } }, { "@type": "Question", "name": "Quels sont les symptômes courants des tumeurs de la moelle osseuse ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Fatigue, douleurs osseuses, infections fréquentes et saignements anormaux." } }, { "@type": "Question", "name": "Comment la moelle osseuse affecte-t-elle la santé globale ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Elle peut entraîner une anémie, des infections et des problèmes de coagulation." } }, { "@type": "Question", "name": "Les symptômes varient-ils selon le type de tumeur ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Oui, chaque type de tumeur peut présenter des symptômes spécifiques." } }, { "@type": "Question", "name": "Y a-t-il des signes d'alerte précoce ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Des saignements inexpliqués et des ecchymoses peuvent être des signes d'alerte." } }, { "@type": "Question", "name": "Les symptômes peuvent-ils être confondus avec d'autres maladies ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, ils peuvent être similaires à ceux d'autres maladies hématologiques." } }, { "@type": "Question", "name": "Peut-on prévenir les tumeurs de la moelle osseuse ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Il n'existe pas de méthode de prévention spécifique, mais un mode de vie sain aide." } }, { "@type": "Question", "name": "Les facteurs environnementaux jouent-ils un rôle ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'exposition à des produits chimiques peut augmenter le risque de tumeurs." } }, { "@type": "Question", "name": "Le tabagisme est-il un facteur de risque ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le tabagisme est associé à un risque accru de plusieurs cancers, y compris ceux de la moelle." } }, { "@type": "Question", "name": "Les antécédents familiaux influencent-ils le risque ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des antécédents familiaux de cancers hématologiques peuvent augmenter le risque." } }, { "@type": "Question", "name": "Y a-t-il des vaccins pour prévenir ces tumeurs ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Actuellement, il n'existe pas de vaccins spécifiques pour prévenir les tumeurs de la moelle." } }, { "@type": "Question", "name": "Quels traitements sont disponibles pour ces tumeurs ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements incluent chimiothérapie, radiothérapie et greffe de moelle osseuse." } }, { "@type": "Question", "name": "La radiothérapie est-elle efficace ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle peut réduire la taille des tumeurs et soulager les symptômes." } }, { "@type": "Question", "name": "Qu'est-ce que la thérapie ciblée ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "C'est un traitement qui cible des anomalies spécifiques des cellules tumorales." } }, { "@type": "Question", "name": "Quand la greffe de moelle osseuse est-elle recommandée ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Elle est souvent recommandée pour les cas avancés ou réfractaires aux traitements." } }, { "@type": "Question", "name": "Quels sont les effets secondaires des traitements ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Les effets secondaires peuvent inclure nausées, fatigue et immunosuppression." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent infections, anémie sévère et défaillance organique." } }, { "@type": "Question", "name": "Comment les infections sont-elles liées aux tumeurs ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Les tumeurs peuvent affaiblir le système immunitaire, rendant les infections plus probables." } }, { "@type": "Question", "name": "Les tumeurs de la moelle osseuse peuvent-elles récidiver ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Oui, il existe un risque de récidive après traitement, nécessitant un suivi régulier." } }, { "@type": "Question", "name": "Quelles sont les conséquences d'une anémie sévère ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Une anémie sévère peut entraîner une fatigue extrême et des complications cardiaques." } }, { "@type": "Question", "name": "Les traitements eux-mêmes peuvent-ils causer des complications ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les traitements comme la chimiothérapie peuvent entraîner des effets secondaires graves." } }, { "@type": "Question", "name": "Quels sont les principaux facteurs de risque ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent l'âge avancé, l'exposition à des radiations et des produits chimiques." } }, { "@type": "Question", "name": "Les maladies génétiques augmentent-elles le risque ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines maladies génétiques comme le syndrome de Down augmentent le risque." } }, { "@type": "Question", "name": "Le sexe influence-t-il le risque de tumeurs ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines tumeurs de la moelle osseuse sont plus fréquentes chez les hommes." } }, { "@type": "Question", "name": "L'obésité est-elle un facteur de risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'obésité est associée à un risque accru de plusieurs types de cancers." } }, { "@type": "Question", "name": "Les infections virales peuvent-elles jouer un rôle ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Certaines infections virales, comme le VIH, peuvent augmenter le risque de tumeurs." } } ] } ] }

Sources (1268 au total)

Prosthetic knee joint infection caused by α-hemolytic Streptococcus species: a case report.

Knee arthroplasty is an orthopedic surgical procedure in which a damaged joint is replaced with an artificial one. It is estimated that 1-2% of knee arthroplasties will encounter infection over their ... In this report, a 50-year-old Iranian woman was diagnosed with prosthetic knee joint infection based on clinical, radiological, and laboratory findings. She was diabetic and had undergone a left total... This report indicated the clinical presentation and management of the patient with prosthetic joint infection in which the patient recovered without any severe complications or surgical intervention....

Comparative genome analysis of Streptococcus strains to identify virulent genes causing neonatal meningitis.

To determine Streptococcus agalactiae genes responsible for causing neonatal meningitis.... Streptococcus agalactiae strain 2603 V/R is causative agent of neonatal meningitis, maternal infection and sepsis in young children. World health organisation reported high burden of new born death ca... To compare the genome of selected strain with the non-pathogenic strains of streptococcus and identify the virulent and antibiotic resistant genes for adaptation in host environment.... The whole genome of human pathogen Streptococcus agalactiae strain 2603 V/R was analysed and compared with Streptococcus dysgalactiae strains using visualization and annotation tools. Genomic islands,... Genetically pathogenic strain is most similar to Streptococcus dysgalactiae subsp. equisimilis strain NCTC 7136. Comparative analysis revealed the importance of capsular polysaccharides and surface pr... The comparative analysis of pathogenic strain Streptococcus agalactiae with non-pathogenic strains of Streptococcus dysgalactiae provided new insights in pathogenicity that could aid in recognization ...

A respiratory Streptococcus strain inhibits Acinetobacter baumannii from causing inflammatory damage through ferroptosis.

Microecological equilibrium is essential for human health. Previous research has demonstrated that Streptococcus strain A, the main bacterial group in the respiratory tract, can suppress harmful micro... The supernatant of fermentation broth of Streptococcus D19... Streptococcus strain D19...

Long-term Risk of Epilepsy Following Invasive Group B Streptococcus Disease in Neonates in Denmark.

The risk of epilepsy after neonatal invasive Group B Streptococcus (iGBS) disease, particularly iGBS sepsis, is poorly understood.... To examine the association between neonatal iGBS (sepsis or meningitis) and long-term risk of epilepsy, stratified by sex, prematurity, and maternal socioeconomic position (SEP).... This population-based cohort study was conducted in Denmark with an inclusion period from 1997 through 2017 and follow-up until the end of 2018. A general population comparison cohort was randomly sam... Hospital-diagnosed iGBS (sepsis or meningitis) during the first 89 days after birth.... Epilepsy was defined by International Statistical Classification of Diseases and Related Health Problems, Tenth Revision codes and/or prescription codes for antiepileptic drugs using Danish medical re... A total of 1432 children (792 [55.3%] boys; 1126 [78.6%] with gestational age ≥37 weeks) were identified with iGBS disease: 1264 with sepsis and 168 with meningitis. In the comparison cohort, there we... In this population-based cohort study of 1432 neonates, iGBS disease was associated with a higher incidence of epilepsy in later childhood, notably after meningitis. Premature birth, sex, and low mate...

Effectiveness of intravenous immunoglobulin therapy for invasive group A Streptococcus infection: A Japanese nationwide observational study.

Invasive group A Streptococcus infection (iGAS) is a rare but fatal condition. We aimed to evaluate the effectiveness of intravenous immunoglobulin (IVIG) in the treatment of iGAS.... Patients' data were extracted from a Japanese nationwide database between April 2018 and March 2021. The primary outcome was in-hospital mortality rate, whereas the secondary outcomes were 30-day and ... Overall, 481 patients (median age, 65 years; female, 49.7%) were included in the analysis. The overall mortality rate was 31.0%. After adjusting for background factors, we found that IVIG treatment ha... IVIG administration had no survival benefit in iGAS patients. However, these overall findings should not be extrapolated to streptococcal toxic shock syndrome as the effect of IVIG therapy in this con...